SCHEMBL1158367

SCHEMBL1158367

O=c1cc(CO)oc(Br)c1O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.50
POLB P06746 3/20 0.50
ALDH1A1 P00352 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TYR P14679 1/20 0.47
DAO P14920 1/20 0.47
TEAD4 Q15561 8/20 0.46
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
GAA P10253 3/20 0.43
TEAD1 P28347 1/20 0.42
TEAD2 Q15562 1/20 0.42
TEAD3 Q99594 1/20 0.42
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3558568 0.82 KDM4E (0.65) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL4526286 0.79 KDM4E (0.53) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL13078827 0.79 KDM4E (0.53) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL3555239 0.76 KDM4E (0.54) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL11332652 0.76 KDM4E (0.50) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL622814 0.76 KDM4E (0.50) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL6786876 0.76 KDM4E (0.50) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL18120558 0.76 KDM4E (0.66) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL13395932 0.73 KDM4E (0.51) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL21173510 0.73 KDM4E (0.59) KDM4EPOLBALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119161317-A Vinyl pyrone compound and application thereof 福建医科大学 2024-12-20 CN disclosed
US-8222279-B2 Small molecule insulin mimetics absent quinones DUKE UNIVERSITY (US) 2012-07-17 US disclosed
US-8222279-B2 Small molecule insulin mimetics absent quinones DUKE UNIVERSITY (US) 2012-07-17 US disclosed
US-8222279-B2 Small molecule insulin mimetics absent quinones DUKE UNIVERSITY (US) 2012-07-17 US disclosed
US-8188144-B2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells ANTOXIS LIMITED (GB) 2012-05-29 US disclosed
US-8188144-B2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells ANTOXIS LIMITED (GB) 2012-05-29 US disclosed
US-20110028519-A1 SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES PIRRUNG MICHAEL C 2011-02-03 US disclosed
US-20110028519-A1 SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES PIRRUNG MICHAEL C 2011-02-03 US disclosed
US-20110028519-A1 SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES PIRRUNG MICHAEL C 2011-02-03 US disclosed
US-7834050-B2 Use of indole compounds such as 3-Hydroxy-6-hydroxymethyl-1-methyl-2-[7-(3-methyl-but-2-enyl)-1H-indol-3-yl]-pyridin-4-one DUKE UNIVERSITY (US) 2010-11-16 US disclosed
US-7834050-B2 Use of indole compounds such as 3-Hydroxy-6-hydroxymethyl-1-methyl-2-[7-(3-methyl-but-2-enyl)-1H-indol-3-yl]-pyridin-4-one DUKE UNIVERSITY (US) 2010-11-16 US disclosed
US-7834050-B2 Use of indole compounds such as 3-Hydroxy-6-hydroxymethyl-1-methyl-2-[7-(3-methyl-but-2-enyl)-1H-indol-3-yl]-pyridin-4-one DUKE UNIVERSITY (US) 2010-11-16 US disclosed
US-20100267132-A1 IN VITRO PRESERVATION OF LIVING ANIMAL CELLS AND COMPOUNDS SUITABLE FOR USE IN THE PRESERVATION OF LIVING ANIMAL CELLS ANTOXIS LIMITED (GB) 2010-10-21 US disclosed
US-20100267132-A1 IN VITRO PRESERVATION OF LIVING ANIMAL CELLS AND COMPOUNDS SUITABLE FOR USE IN THE PRESERVATION OF LIVING ANIMAL CELLS ANTOXIS LIMITED (GB) 2010-10-21 US disclosed
US-20070232663-A1 SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-10-04 US disclosed
US-20070232663-A1 SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-10-04 US disclosed
US-20070232663-A1 SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028519-A1 SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES IAPP, GPR119, IRS1 KDM4E 3960/4885POLB 1766/4885ALDH1A1 1176/4885
US-20100267132-A1 IN VITRO PRESERVATION OF LIVING ANIMAL CELLS AND COMPOUNDS SUITABLE FOR USE IN THE PRESERVATION OF LIVING ANIMAL CELLS PIGS, AQP1, F12 KDM4E 1441/4885POLB 2624/4885ALDH1A1 4/4885
US-20070232663-A1 SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES IAPP, GPR119, IRS1 KDM4E 3960/4885POLB 1766/4885ALDH1A1 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.